Skip to content
Search
SEARCH FOR AN ARTICLE
Home
investing in biotech
investing in biotech
![Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development]()
January 3, 2023
![Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference]()
January 3, 2023
![Apellis Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference]()
January 3, 2023
![argenx to Present at 41st Annual J.P. Morgan Healthcare Conference]()
January 3, 2023
![Axsome (AXSM) Rides on New Drug Approval & Sunosi Buyout]()
December 30, 2022
![Are Investors Undervaluing BioNTech (BNTX) Right Now?]()
December 29, 2022
![Down -41.38% in 4 Weeks, Here’s Why Allogene Therapeutics (ALLO) Looks Ripe for a Turnaround]()
December 29, 2022
![Zacks.com featured highlights Halozyme Therapeutics, Arista Networks and Citizens Financial Group]()
December 29, 2022
![Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference]()
December 28, 2022
![3 Beaten-Down Drug Stocks Poised for a Turnaround in 2023]()
December 28, 2022
